2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) modulates epidermal growth factor (EGF) binding to basal cells from a human keratinocyte cell line
- 1 March 1986
- journal article
- research article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 82 (3) , 481-492
- https://doi.org/10.1016/0041-008x(86)90283-8
Abstract
No abstract availableThis publication has 43 references indexed in Scilit:
- Reversible inhibition of in vitro epithelial cell proliferation by 2,3,7,8-tetrachlorodibenzo-p-dioxinToxicology and Applied Pharmacology, 1984
- Calcium-Regulated Differentiation of Normal Human Epidermal Keratinocytes in Chemically Defined Clonal Culture and Serum-Free Serial CultureJournal of Investigative Dermatology, 1983
- Interactions between the receptors for platelet-derived growth factor and epidermal growth factor.The Journal of cell biology, 1983
- Chloracne and its potential clinical implicationsClinical and Experimental Dermatology, 1981
- Epidermal growth factor receptorsMolecular and Cellular Biochemistry, 1981
- 2,3,7,8-Tetrachlorodibenzo-p-dioxin tissue distribution, excretion, and effects on clinical chemical parameters in guinea pigsToxicology and Applied Pharmacology, 1979
- Epidermal Growth FactorAnnual Review of Biochemistry, 1979
- Terminal differentiation of cultured human epidermal cellsCell, 1977
- 125I-labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts.The Journal of cell biology, 1976
- A modification of the mallory connective tissue stain as a stain for keratinOral Surgery, Oral Medicine, Oral Pathology, 1963